Page 27 - Bharat Biotech
CEPI to grant $14 mn for trial of Bharat Biotech's Chikungunya vaccine
The vaccine completed standard pre-clinical studies, and an optimum immune response was elicited by the adjuvant vaccine in phase-1 trials in India
 "CEPI to grant $14 mn for trial of Bharat Biotech's Chikungunya vaccine")
Covid-19 vaccine development moving positively, says Bharat Biotech CEO
He expressed satisfaction on the progress of the research connected with the vaccine development so far, but insisted that "in science, things can change"
 "Covid-19 vaccine development moving positively, says Bharat Biotech CEO")
Bharat Biotech working on Covid-19 vaccine using dormant rabies inoculation
Ties up with Thomas Jefferson University to develop a vaccine candidate that showed a strong antibody response in mice
 "Bharat Biotech working on Covid-19 vaccine using dormant rabies inoculation")
India coronavirus dispatch: The search for a cure, and India's response
From the SARS-CoV-2 strain in India, to migrant workers in this lockdown, and whether ultraviolet light can help detect and kill coronavirus - read these and more in today's India dispatch
 "India coronavirus dispatch: The search for a cure, and India's response")
ICMR teams up with Bharat Biotech Limited to develop coronavirus vaccine
The vaccine will be developed using the virus strain isolated at the ICMR's National Institute of Virology (NIV), Pune, a statement said.
 "ICMR teams up with Bharat Biotech Limited to develop coronavirus vaccine")
Not just bigwigs, Mid-rung local players join coronavirus vaccine race
With vaccines of some firms already in animal trial phase, developers say that if all goes well, India could have a vaccine by next year
 "Not just bigwigs, Mid-rung local players join coronavirus vaccine race")
Bharat Biotech joins global efforts in developing coronavirus vaccine
CoroFlu will build on the backbone of vaccine firm FluGen's flu vaccine candidate, a self-limiting version of the influenza virus that induces an immune response against the flu.
 "Bharat Biotech joins global efforts in developing coronavirus vaccine")
Bharat Biotech to collaborate with Hilleman to develop cholera vaccine
Hillchol was designed at the University of Gothenburg in Sweden and subsequently developed by Hilleman Labs
 "Bharat Biotech to collaborate with Hilleman to develop cholera vaccine")
Bharat Biotech to acquire GSK's Indian vaccine firm for undisclosed sum
Target company is a single-product vaccine maker with an installed capacity of 15 million doses of anti-rabies vaccine a year; revenues were Rs 180 cr last year
 "Bharat Biotech to acquire GSK's Indian vaccine firm for undisclosed sum")
Bharat Biotech's typhoid vaccine gets WHO pre-qualification
Typbar TCV is a result of dedicated product development at Bharat Biotech since 2001
 "Bharat Biotech's typhoid vaccine gets WHO pre-qualification")
Bharat Biotech's typhoid vaccine rated high in latest human trials
Vaccine is safe, 100% immunogenic, and prevents 55% of typhoid infections in the challenge trial and up to 87% infections
